Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 USD | -2.17% | -9.52% | -88.56% |
May. 09 | GlycoMimetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.56% | 17.4M | |
+7.52% | 113B | |
+11.38% | 106B | |
+1.66% | 22.27B | |
-12.64% | 22.22B | |
-5.20% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- GLYC Stock
- News GlycoMimetics, Inc.
- Transcript : GlycoMimetics, Inc., Q4 2020 Earnings Call, Mar 02, 2021